搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
15 小时
on MSN
Eli Lilly (LLY): Revenue Boost from Zepbound and Mounjaro Amid Strong Market Projections
We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where Eli ...
Fintel on MSN
23 小时
Bernstein Initiates Coverage of Eli Lilly and (LLY) with Outperform Recommendation
Fintel reports that on October 17, 2024, Bernstein initiated coverage of Eli Lilly and (NYSE:LLY) with a Outperform ...
16 小时
Why Eli Lilly Stock Is Soaring—And How It Plans To Stay On Top
In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. It is now the most valuable pharmaceutical company in the world.
FiercePharma
23 小时
Fierce Pharma Asia—Lilly's China expansions; Gilead's scrapped MASH deal; Leqembi's vial ...
Eli Lilly is making a series of investments in China to support its manufacturing and R&D operations. Gilead Sciences has ...
FiercePharma
20 小时
Lilly joins OAC campaign against obesity stigma, partnering on gallery of bias-free images ...
Since 2021, the Obesity Action Coalition (OAC) has led a national public awareness campaign against weight bias with a goal ...
2 小时
Investing $10,000 in Each of These 3 Stocks 10 Years Ago Would Have Made You $1.1 Million
To make $1 million in the stock market, you don't need to invest a fortune. But you'll definitely want to take the time to ...
BioSpace
20 小时
It’s Earnings Season. Here’s What to Watch for Following J&J Beat
This week marked the start of the third-quarter earnings season, with Johnson & Johnson exceeding Wall Street’s expectations.
Medscape
22 小时
Vestibular Migraine: Less Dizziness With Galcanezumab
In the first randomized controlled trial in patients with vestibular migraine, galcanezumab outperformed placebo in reducing ...
20 小时
Is Amgen Stock a Buy?
Amgen (NASDAQ: AMGN) stock is up 13% this year but has struggled to break out above a tight trading range in recent months.
The Lancet
12 小时
Driving down the cost of biologics: lessons from a nationalised health-care system
Few treatments have revolutionised care for people with chronic inflammatory disorders more than biologic and small molecule ...
17 小时
Judge Shuts Down Efforts to Expand Scope of Discovery in Ozempic MDL
Judge Karen Marston held that, despite plaintiffs' arguments to the contrary, marketing discovery is not relevant to the ...
BusinessMirror
19 小时
Obesity drugs for elderly Americans seen costing Medicare $35 billion
Giving older Americans access to weight-loss medicines through the US Medicare program would cost $35 billion over nine years, according to a congressional analysis. Expanding coverage of weight-loss ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈